Abdominal obesity and breast cancer risk.

PubWeight™: 1.83‹?› | Rank: Top 3%

🔗 View Article (PMID 2297194)

Published in Ann Intern Med on February 01, 1990

Authors

D V Schapira1, N B Kumar, G H Lyman, C E Cox

Author Affiliations

1: H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

Articles citing this

Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol (2002) 3.16

Obesity, inflammation, and liver cancer. J Hepatol (2011) 2.09

Early gastric cancer shows different associations with adipose tissue volume depending on histological type. Gastric Cancer (2008) 1.42

Waist-hip ratio and breast cancer risk in urbanized Nigerian women. Breast Cancer Res (2002) 1.18

Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev (2014) 1.17

Insulin-like growth factors: the unrecognised oncogenes. Br J Cancer (1995) 1.17

Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas. Hum Mol Genet (2012) 1.11

Body fat distribution in the Finnish population: environmental determinants and predictive power for cardiovascular risk factor levels. J Epidemiol Community Health (1991) 1.03

Chemotherapy dosing in overweight and obese patients with cancer. Nat Rev Clin Oncol (2013) 1.02

High-risk mammographic parenchymal patterns and anthropometric measures: a case-control study. Br J Cancer (1999) 1.00

Glucose promotes breast cancer aggression and reduces metformin efficacy. Cell Cycle (2013) 0.99

Association of overweight and obesity with breast cancer in India. Indian J Community Med (2011) 0.96

Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res (2005) 0.95

Breast cancer: the obesity connection. Br J Cancer (1994) 0.91

Body fat and breast cancer risk in postmenopausal women: a longitudinal study. J Cancer Epidemiol (2013) 0.84

Breast cancer hypothesis: a single cause for the majority of cases. J Epidemiol Community Health (2000) 0.83

Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link? Gut (2007) 0.79

Genotype-environment interactions for quantitative traits in Korea Associated Resource (KARE) cohorts. BMC Genet (2014) 0.78

Fatty metamorphosis of the liver in patients with breast cancer: possible associated factors. World J Gastroenterol (2003) 0.77

A prospective study on obesity and subcutaneous fat patterning in relation to breast cancer in post-menopausal women participating in the DOM project. Br J Cancer (1994) 0.75

Body fat distribution and risk for breast cancer. Ann Intern Med (1990) 0.75

Associations of anthropometric measures on breast cancer risk in pre- and postmenopausal women-a case-control study. J Physiol Anthropol (2016) 0.75

Articles by these authors

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20

The uncertainty principle and industry-sponsored research. Lancet (2000) 7.75

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer (2010) 4.95

Environmental tobacco smoke and lung cancer risk in nonsmoking women. J Natl Cancer Inst (1992) 4.19

Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA (1996) 4.13

Comorbidity and functional status are independent in older cancer patients. J Clin Oncol (1998) 4.11

Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene (2001) 3.96

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer (2006) 3.78

Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc Natl Acad Sci U S A (1988) 3.23

Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost (2007) 3.22

Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg (1998) 2.90

The histopathologic spectrum of acute self-limited colitis (acute infectious-type colitis). Am J Surg Pathol (1982) 2.48

Methodological challenges in the evaluation of prognostic factors in breast cancer. Breast Cancer Res Treat (1998) 2.28

Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol (1998) 2.27

Cost-effectiveness of white cell-reduction filters in treatment of adult acute myelogenous leukemia. Transfusion (1993) 2.04

Bacteriologic and pharmacodynamic aspects of nalidixic acid. J Urol (1970) 1.95

Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage (1999) 1.89

Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases. Cancer (1982) 1.82

Linking evidence-based medicine therapeutic summary measures to clinical decision analysis. MedGenMed (2000) 1.71

Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer. Ann Surg Oncol (1998) 1.64

Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA (1998) 1.62

Membrane action of DMSO and other chemical inducers of Friend leukaemic cell differentiation. Nature (1976) 1.59

Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology (1998) 1.57

The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. J Am Coll Surg (2001) 1.53

Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol (1999) 1.50

Influence of physician communication on newly diagnosed breast patients' psychologic adjustment and decision-making. Cancer (1994) 1.46

Obesity and body fat distribution and breast cancer prognosis. Cancer (1991) 1.46

Pregnancy-associated hospitalizations in the United States in 1991 and 1992: a comprehensive view of maternal morbidity. Am J Obstet Gynecol (1998) 1.43

Prevention of venous thromboembolism in hospitalized medical cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost (2014) 1.39

Screening mammography in the Tampa Bay area: current status and implications for the next decade. J Fla Med Assoc (1989) 1.39

Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol (2000) 1.38

Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol (2001) 1.38

Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg (1995) 1.35

Histopathology differentiates acute self-limited colitis from ulcerative colitis. Gastroenterology (1987) 1.34

Quality of life after adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat (2000) 1.33

Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina. J Am Coll Cardiol (2000) 1.31

The urethra and its relationship to urinary tract infection. II. The urethral flora of the female with recurrent urinary infection. J Urol (1968) 1.29

Pharmaceutical care research and education project: patient outcomes. J Am Pharm Assoc (Wash) (2001) 1.28

Pharmaceutical care research and education project: pharmacists' interventions. J Am Pharm Assoc (Wash) (2001) 1.27

Gentamicin. Med Clin North Am (1970) 1.27

The urethra and its relationship to urinary tract infection: the flora of the normal female urethra. South Med J (1966) 1.22

NCCN Practice Guidelines for Breast Cancer. Oncology (Williston Park) (2000) 1.22

Impact of smoking and smokeless tobacco on the risk of cancer of the head and neck. Head Neck Surg (1987) 1.17

Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg (2001) 1.15

The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg (1999) 1.14

Perineal, vaginal and urethral bacteriology of young women. I. Incidence of gram-negative colonization. J Urol (1974) 1.13

Risk factors for bladder tumors in spinal cord injury patients. J Urol (1996) 1.11

Tools used to help community pharmacists implement comprehensive pharmaceutical care. J Am Pharm Assoc (Wash) (2000) 1.08

Fournier's gangrene: therapeutic impact of hyperbaric oxygen. Plast Reconstr Surg (1998) 1.07

Android obesity at diagnosis and breast carcinoma survival: Evaluation of the effects of anthropometric variables at diagnosis, including body composition and body fat distribution and weight gain during life span,and survival from breast carcinoma. Cancer (2000) 1.06

Association of leukemia with radium groundwater contamination. JAMA (1985) 1.06

What threshold for adjuvant therapy in older breast cancer patients? J Clin Oncol (2000) 1.02

A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection. Urology (1998) 1.02

Gentamicin, a new aminoglycoside antibiotic: clinical and laboratory studies in urinary tract infection. J Infect Dis (1969) 1.01

Obesity, body fat distribution, and sex hormones in breast cancer patients. Cancer (1991) 1.00

Serum hepatic enzyme and bilirubin elevations during parenteral nutrition. Surg Gynecol Obstet (1977) 1.00

Importance of delayed imaging for blunt renal trauma. World J Surg (2001) 0.99

The use of lithium carbonate to reduce infection and leukopenia during systemic chemotherapy. N Engl J Med (1980) 0.99

Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Annu Rev Med (2000) 0.97

Hematopoietic growth factors in the older cancer patient. Curr Opin Hematol (2001) 0.97

Aztreonam therapy for complicated urinary tract infections caused by multidrug-resistant bacteria. Rev Infect Dis (1986) 0.97

The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Cancer (1995) 0.97

Phospholipid membrane stabilization by dimethylsulfoxide and other inducers of Friend leukemic cell differentiation. Biochim Biophys Acta (1976) 0.97

Clinical study evaluating efficacy of praziquantel in clonorchiasis. Antimicrob Agents Chemother (1987) 0.96

The voiding vesical defense mechanism: the mathematical effect of residual urine, voiding interval and volume on bacteriuria. J Urol (1966) 0.95

Hemopoietic reserve in the older cancer patient: clinical and economic considerations. Cancer Control (2001) 0.95

Carcinoma of the vagina. Factors influencing treatment outcome. Cancer (1985) 0.94

Incidental thyroid nodules on CT: evaluation of 2 risk-categorization methods for work-up of nodules. AJNR Am J Neuroradiol (2013) 0.93

A closer look at social support as a moderator of stress in breast cancer. Health Soc Work (1994) 0.93

Primary sarcoma of the adult vagina: a clinicopathologic study. Obstet Gynecol (1985) 0.93

Learning curves and certification for breast cancer lymphatic mapping. Surg Oncol Clin N Am (1999) 0.93

Importance of race on breast cancer survival. Ann Surg Oncol (1997) 0.93

Localization of I-131-labeled goat and primate anti-carcinoembryonic antigen(CEA) antibodies in patients with cancer. Invest Radiol (1982) 0.92

Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: results from an integrated analysis. Eur J Cancer (2008) 0.92

Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology, and lymph node status. Cancer (1992) 0.91

Father involvement and children's functioning at age 6 years: a multisite study. Child Maltreat (2001) 0.91

The effect of sentinel node selective axillary lymphadenectomy on the incidence of postmastectomy pain syndrome. Cancer Control (2001) 0.91

Bacterial inhibition of ureteral smooth muscle contractility. I. The effect of common urinary pathogens and endotoxin in an in vitro system. J Urol (1972) 0.91

Visceral obesity and breast cancer risk. Cancer (1994) 0.90

Cigarette smoking and the risk of female reproductive cancer. Am J Obstet Gynecol (1987) 0.90

Autopsy findings in patients with uterine sarcoma. Gynecol Oncol (1984) 0.90

A comparison of ceftazidime and tobramycin in the treatment of complicated urinary tract infections. J Antimicrob Chemother (1983) 0.90

Relation of results of exercise stress tests in young women to phases of the menstrual cycle. Am J Cardiol (1988) 0.89

A preliminary report on the supraoptic nucleus and control of intraocular pressure. Invest Ophthalmol (1975) 0.89

The value of current nutrition information. Prev Med (1990) 0.89

Evidentiary challenges to evidence-based medicine. J Eval Clin Pract (2000) 0.89

Oral norfloxacin versus parenteral treatment of nosocomial urinary tract infection. Am J Med (1987) 0.89

Immunologic and steroid binding properties of the GCDFP-24 protein isolated from human breast gross cystic disease fluid. Breast Cancer Res Treat (1990) 0.89

Factors affecting the incidence of infectious morbidity after radical hysterectomy. Am J Obstet Gynecol (1985) 0.89

Imprint cytology of needle-localized breast lesions. Acta Cytol (1993) 0.88

Clinical experience with ofloxacin in urinary tract infection. Infection (1986) 0.88

Utility of internal mammary lymph node removal when noted by intraoperative gamma probe detection. Ann Surg Oncol (2001) 0.87

Pulmonary Hodgkin's disease. Diagnosis by fine needle aspiration. Acta Cytol (1988) 0.87

Anti-c-myc DNA increases differentiation and decreases colony formation by HL-60 cells. In Vitro Cell Dev Biol (1989) 0.87